MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells.

导出 OA

翻译打印收藏纠错

作者： Danxia,Cao ^[1] ; Han,Zhu ^[2] ; Qian,Zhao ^[3] ; Jianming,Huang ^[4] ; Cixiang,Zhou ^[3] ; Jianrong,He ^[5] ; Yongjun,Liang ^[6]

作者单位： Comprehensive Breast Health Center, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Rui-Jin Er Road, Shanghai, 200025, China. ^[1] Department of Pharmacy, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, No. 2800, Gong-Wei Road, Shanghai, 201399, China. ^[2] Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Jiao Tong University School of Medicine, No. 280, Chong-Qing South Road, Shanghai, 200025, China. ^[3] Department of Orthopedics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, No. 2800, Gong-Wei Road, Shanghai, 201399, China. ^[4] Comprehensive Breast Health Center, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Rui-Jin Er Road, Shanghai, 200025, China. hejrong@hotmail.com. ^[5] Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, No. 2800, Gong-Wei Road, Shanghai, 201399, China. liangyj0214@qq.com. ^[6]

关键词 Breast cancer MTDH Metastasis miR-128